Misonix to Report Fiscal 2019 Second Quarter Financial Results and Host Conference Call and Webcast on February 6
January 22 2019 - 10:00AM
Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, announced today that it
will report its fiscal 2019 second quarter financial results after
the market closes on Wednesday, February 6, 2019. The Company will
host a conference call and webcast at 4:30 p.m. ET that day to
review the results. Both the call and webcast are open to the
general public.
To access the conference call, interested
parties may dial 888/599-8686 (domestic) or 323/994-2093
(international) conference ID 9194323. Participants may also listen
to a live webcast of the call through the “Events and
Presentations” section under “Investor Relations” on Misonix’s
website at www.misonix.com. A webcast replay will be available for
30 days following the live event at www.misonix.com.
Please call five minutes in advance to ensure
that you are connected. Questions and answers will be taken only
from participants on the conference call. For the webcast, please
allow 15 minutes to register, download and install any necessary
software.
About Misonix, Inc.Misonix,
Inc. (NASDAQ: MSON) designs, develops, manufactures and markets
ultrasonic medical devices for the precise removal of hard and soft
tissue, including bone removal, wound debridement and ultrasonic
aspiration. Misonix is focused on leveraging its proprietary
ultrasonic technology to become the standard of care in operating
rooms and clinics around the world. Misonix's proprietary
ultrasonic medical devices are used in a growing number of medical
procedures, including spine surgery, neurosurgery, orthopedic
surgery, cosmetic surgery, laparoscopic surgery, and other surgical
and medical applications. At Misonix, Better Matters to us. That is
why throughout the Company’s history, Misonix has maintained its
commitment to medical technology innovation and the development of
ultrasonic surgical products that radically improve patient
outcomes. Additional information is available on the Company's web
site at www.misonix.com.
Contact:Joe DwyerChief Financial
OfficerMisonix, Inc.631-927-9113
Joseph Jaffoni, Norberto Aja, Jennifer NeumanJCIR212-835-8500 or
mson@jcir.com
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2023 to Apr 2024